Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart

Cell Biology International

Volumn 34, Issue 4, 2010, Pages 415-423

  Wang, Deguo ^a   Shen, Wenzhi ^a   Zhang, Fengxiang ^a   Chen, Minglong ^a   Chen, Hongwu ^a   Cao, Kejiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; Bcl 2; Connexin43; Mesenchymal stem cells; Myocardial infarction

Indexed keywords

CONNEXIN 43; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL ISOLATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; ECHOCARDIOGRAPHY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; RNA INTERFERENCE; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; CELL HYPOXIA; CELL SURVIVAL; CONNEXIN 43; DISEASE MODELS, ANIMAL; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 77953919762     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090118     Document Type: Article

References (27)

1. Amsalem Y, Mardor Y, Feinberg MS, Landa N, Miller L, Daniels D et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 2007;116:I38-45.
2. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007;50:1884-93.
3. Contreras JE, Sanchez HA, Veliz LP, Bukauskas FF, Bennett MV, Saez JC. Role of connexion-based gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Res Brain Res Rev 2004;47:290-303.
4. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, Kloner RA. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short-and long-term effects. Circulation 2005;112:214-23.
5. Danik SB, Rosner G, Lader J, Gutstein DE, Fishman GI, Morley GE. Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts. FASEB J 2008;22:1204-12.
6. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516.
7. Giardina SF, Mikami M, Goubaeva F, Yang J. Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis. Biochem Biophys Res Commun 2007;362:747-52.
8. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11:367-8.
9. Goubaeva F, Mikami M, Giardina S, Ding B, Abe J, Yang J. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem Biophys Res Commun 2007;352:97-103.
10. Grauss RW, van Tuyn J, Steendijk P, Winter EM, Pijnappels DA, Hogers B et al. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 2008; 26:1083-1093.
11. Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH et al. Pretreatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol 2008;51:933-43.
12. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA, 2003;100:7808-11.
13. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007;25:2118-27.
14. Lu G, Haider HK, Jiang S, Ashraf M. Sca-1+ stem cell survival and engraftment in the infarcted heart. Dual role for preconditioninginduced connexion-43. Circulation 2009;119:2587-96.
15. Mangi AA, Noiseux N, Kong D, He H, Rezvani M, Ingwall JS, Dzau VJ. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9: 1195-201.
16. Muller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 2006;41:876-84.
17. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-35.
18. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004:10(5):494-501.
19. Olivares EL, Ribeiro VP, Werneck de Castro JP, Ribeiro KC, Mattos EC, Goldenberg RC et al. Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts. Am J Physiol Heart Circ Physiol 2004;287:H464-70.
20. Pijnappels DA, Schalij MJ, van Tuyn J, Ypey DL, de Vries AA, van der Wall EE et al. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res 2006;72:282-91.
21. Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M et al. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 2006;99:93-101.
22. Rosova I, Dao M, Capoccia B, Link D, Nolta JA. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008;26: 2173-82.
23. Rossello RA, Wang Z, Kizana E, Krebsbach PH, Kohn DH. Connexin 43 as a signaling platform for increasing the volume and spatial distribution of regenerated tissue. Proc Natl Acad Sci USA, 2009;106:13219-24.
24. Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxiaregulated heme oxygenase-1 vector. J Am Coll Cardiol 2005;46:1339-50.
25. Tse HF, Thambar S, Kwong YL, Rowlings P, Bellamy G, McCrohon J et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). Eur Heart J 2007;28:2998-3005.
26. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA et al. Comparison of transplantation of adipose tissue-and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009;87:642-52.
27. Yasui K, Kada K, Hojo M, Lee JK, Kamiya K, Toyama J, Opthof T, Kodama I. Cell-to-cell interaction prevents cell death in cultured neonatal rat ventricular myocytes. Cardiovasc Res 2000;48: 68-76.